Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

Published Date: 13 Sep 2024

Two-trial analysis shows about a 40% decreased risk of disease recurrence or death

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

2.

According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.

3.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

4.

Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control

5.

A prostate cancer risk prediction algorithm could help target men at highest risk


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot